X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AMAR REMEDIES with Karuturi Global - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs KARUTURI GLOBAL - Comparison Results

KARUTURI GLOBAL 
   Change

Karuturi Global (KGL), based in Bangalore, and having operations in Kenya and Ethiopia, is the world's largest producer of cut roses. The company's total capacity currently stands at around 700 m stems per annum. It cultivates 10 hectares of rose far... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES KARUTURI GLOBAL AMAR REMEDIES/
KARUTURI GLOBAL
 
P/E (TTM) x -0.5 7.1 - View Chart
P/BV x 0.1 0.1 49.8% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 AMAR REMEDIES   KARUTURI GLOBAL
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
KARUTURI GLOBAL
Mar-14
AMAR REMEDIES/
KARUTURI GLOBAL
5-Yr Chart
Click to enlarge
High Rs1644 4,315.8%   
Low Rs861 14,333.3%   
Sales per share (Unadj.) Rs261.66.1 4,296.5%  
Earnings per share (Unadj.) Rs17.40.9 2,038.2%  
Cash flow per share (Unadj.) Rs22.31.3 1,671.1%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs100.723.0 438.2%  
Shares outstanding (eoy) m26.16809.73 3.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.50.4 132.2%   
Avg P/E ratio x7.22.6 278.8%  
P/CF ratio (eoy) x5.61.6 340.0%  
Price / Book Value ratio x1.20.1 1,296.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m3,2701,781 183.6%   
No. of employees `000NANA-   
Total wages/salary Rs m163343 47.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m6,8444,931 138.8%  
Other income Rs m21244 8.6%   
Total revenues Rs m6,8655,175 132.7%   
Gross profit Rs m1,1311,259 89.8%  
Depreciation Rs m128389 32.9%   
Interest Rs m398726 54.8%   
Profit before tax Rs m626388 161.2%   
Minority Interest Rs m00 0.0%   
Prior Period Items Rs m0-136 0.0%   
Extraordinary Inc (Exp) Rs m-50204 -24.5%   
Tax Rs m121-235 -51.4%   
Profit after tax Rs m455691 65.8%  
Gross profit margin %16.525.5 64.7%  
Effective tax rate %19.3-60.6 -31.9%   
Net profit margin %6.614.0 47.4%  
BALANCE SHEET DATA
Current assets Rs m4,9043,811 128.7%   
Current liabilities Rs m3,5816,763 53.0%   
Net working cap to sales %19.3-59.9 -32.3%  
Current ratio x1.40.6 243.0%  
Inventory Days Days12416 783.3%  
Debtors Days Days100124 80.9%  
Net fixed assets Rs m1,68926,264 6.4%   
Share capital Rs m262810 32.4%   
"Free" reserves Rs m2,35815,785 14.9%   
Net worth Rs m2,63518,613 14.2%   
Long term debt Rs m5074,976 10.2%   
Total assets Rs m6,86230,598 22.4%  
Interest coverage x2.61.5 167.6%   
Debt to equity ratio x0.20.3 72.0%  
Sales to assets ratio x1.00.2 618.9%   
Return on assets %12.44.6 268.4%  
Return on equity %17.33.7 465.1%  
Return on capital %31.05.0 618.6%  
Exports to sales %4.00.9 452.1%   
Imports to sales %00-   
Exports (fob) Rs m27344 627.6%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m27344 627.6%   
Fx outflow Rs m20 5,000.0%   
Net fx Rs m27143 623.6%   
CASH FLOW
From Operations Rs m-3134,367 -7.2%  
From Investments Rs m-489-3,984 12.3%  
From Financial Activity Rs m769-255 -301.7%  
Net Cashflow Rs m-33129 -25.2%  

Share Holding

Indian Promoters % 25.5 5.5 463.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 9.2 0.2 4,600.0%  
FIIs % 0.0 15.8 -  
ADR/GDR % 0.0 1.3 -  
Free float % 65.3 77.2 84.6%  
Shareholders   13,061 70,503 18.5%  
Pledged promoter(s) holding % 99.7 22.4 445.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   K.S.OILS LTD  GODREJ INDUSTRIES  HIND. UNILEVER  MARICO LTD  BATA INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Of Global Markets Hitting Record Highs and Top Stocks in Action During the Week(RoundUp)

Global stock markets ended the week on a positive note. Benchmark indices in US grew by 1% during the week. The Down Jones Industrial Average topped the 26,000.

Related Views on News

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 5-YR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS